ID   TCPA_HUMAN              Reviewed;         556 AA.
AC   P17987; E1P5B2; Q15556; Q5TCM3;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 1.
DT   28-JAN-2026, entry version 238.
DE   RecName: Full=T-complex protein 1 subunit alpha;
DE            Short=TCP-1-alpha;
DE            EC=3.6.1.- {ECO:0000305|PubMed:35449234, ECO:0000305|PubMed:36493755, ECO:0000305|PubMed:37193829};
DE   AltName: Full=CCT-alpha;
DE   AltName: Full=Chaperonin containing T-complex polypeptide 1 subunit 1 {ECO:0000312|MIM:186980};
GN   Name=TCP1 {ECO:0000303|PubMed:2377466, ECO:0000303|PubMed:3653076,
GN   ECO:0000312|HGNC:HGNC:11655};
GN   Synonyms=CCT1 {ECO:0000303|PubMed:25467444,
GN   ECO:0000312|HGNC:HGNC:11655}, CCTA {ECO:0000312|HGNC:HGNC:11655};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Testis;
RX   PubMed=2377466; DOI=10.1093/nar/18.14.4247;
RA   Kirchhoff C., Willison K.R.;
RT   "Nucleotide and amino-acid sequence of human testis-derived TCP1.";
RL   Nucleic Acids Res. 18:4247-4247(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 1-11, AND ACETYLATION AT MET-1.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R.,
RA   Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass spectrometric
RT   identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [7]
RP   PROTEIN SEQUENCE OF 112-122; 131-145; 248-264; 469-480 AND 516-526, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Vishwanath V.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 308-365 AND 462-516.
RX   PubMed=3653076; DOI=10.1002/j.1460-2075.1987.tb02459.x;
RA   Willison K., Kelly A., Dudley K., Goodfellow P., Spurr N., Groves V.,
RA   Gorman P., Sheer D., Trowsdale J.;
RT   "The human homologue of the mouse T-complex gene, TCP1, is located on
RT   chromosome 6 but is not near the HLA region.";
RL   EMBO J. 6:1967-1974(1987).
RN   [9]
RP   SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=1630492; DOI=10.1038/358249a0;
RA   Lewis V.A., Hynes G.M., Zheng D., Saibil H., Willison K.R.;
RT   "T-complex polypeptide-1 is a subunit of a heteromeric particle in the
RT   eukaryotic cytosol.";
RL   Nature 358:249-252(1992).
RN   [10]
RP   INTERACTION WITH PACRG.
RX   PubMed=14532270; DOI=10.1074/jbc.m309655200;
RA   Imai Y., Soda M., Murakami T., Shoji M., Abe K., Takahashi R.;
RT   "A product of the human gene adjacent to parkin is a component of Lewy
RT   bodies and suppresses Pael receptor-induced cell death.";
RL   J. Biol. Chem. 278:51901-51910(2003).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-544, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-181 AND SER-544, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-199 AND LYS-400, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [18]
RP   FUNCTION, SUBCELLULAR LOCATION, AND IDENTIFICATION IN THE
RP   CHAPERONIN-CONTAINING T-COMPLEX.
RX   PubMed=20080638; DOI=10.1073/pnas.0910268107;
RA   Seo S., Baye L.M., Schulz N.P., Beck J.S., Zhang Q., Slusarski D.C.,
RA   Sheffield V.C.;
RT   "BBS6, BBS10, and BBS12 form a complex with CCT/TRiC family chaperonins and
RT   mediate BBSome assembly.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:1488-1493(2010).
RN   [19]
RP   INTERACTION WITH GBA1.
RX   PubMed=21098288; DOI=10.1073/pnas.1014376107;
RA   Lu J., Chiang J., Iyer R.R., Thompson E., Kaneski C.R., Xu D.S., Yang C.,
RA   Chen M., Hodes R.J., Lonser R.R., Brady R.O., Zhuang Z.;
RT   "Decreased glucocerebrosidase activity in Gaucher disease parallels
RT   quantitative enzyme loss due to abnormal interaction with TCP1 and c-Cbl.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:21665-21670(2010).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-544 AND SER-551, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-544 AND SER-551, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [23]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [24]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [25]
RP   FUNCTION, AND IDENTIFICATION IN THE CHAPERONIN-CONTAINING T-COMPLEX.
RX   PubMed=25467444; DOI=10.1016/j.cell.2014.10.059;
RA   Freund A., Zhong F.L., Venteicher A.S., Meng Z., Veenstra T.D., Frydman J.,
RA   Artandi S.E.;
RT   "Proteostatic control of telomerase function through TRiC-mediated folding
RT   of TCAB1.";
RL   Cell 159:1389-1403(2014).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6; SER-491; SER-544 AND
RP   SER-551, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-544, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [29]
RP   INTERACTION WITH DLEC1.
RX   PubMed=33144677; DOI=10.1038/s41598-020-75957-y;
RA   Okitsu Y., Nagano M., Yamagata T., Ito C., Toshimori K., Dohra H.,
RA   Fujii W., Yogo K.;
RT   "Dlec1 is required for spermatogenesis and male fertility in mice.";
RL   Sci. Rep. 10:18883-18883(2020).
RN   [30] {ECO:0007744|PDB:7TRG, ECO:0007744|PDB:7TTN, ECO:0007744|PDB:7TTT, ECO:0007744|PDB:7TUB, ECO:0007744|PDB:7WU7}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.90 ANGSTROMS) IN COMPLEX WITH TUBULIN,
RP   FUNCTION, SUBUNIT, ADP AND MG(2+) BINDING SITES, AND CATALYTIC ACTIVITY.
RX   PubMed=36493755; DOI=10.1016/j.cell.2022.11.014;
RA   Gestaut D., Zhao Y., Park J., Ma B., Leitner A., Collier M., Pintilie G.,
RA   Roh S.H., Chiu W., Frydman J.;
RT   "Structural visualization of the tubulin folding pathway directed by human
RT   chaperonin TRiC/CCT.";
RL   Cell 185:4770-4787.e20(2022).
RN   [31] {ECO:0007744|PDB:7NVL, ECO:0007744|PDB:7NVM, ECO:0007744|PDB:7NVN, ECO:0007744|PDB:7NVO}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.50 ANGSTROMS) IN COMPLEX WITH TUBULIN
RP   AND IN COMPLEX WITH ACTIN, FUNCTION, SUBUNIT, ADP AND MG(2+) BINDING SITES,
RP   AND CATALYTIC ACTIVITY.
RX   PubMed=35449234; DOI=10.1038/s41594-022-00755-1;
RA   Kelly J.J., Tranter D., Pardon E., Chi G., Kramer H., Happonen L.,
RA   Knee K.M., Janz J.M., Steyaert J., Bulawa C., Paavilainen V.O.,
RA   Huiskonen J.T., Yue W.W.;
RT   "Snapshots of actin and tubulin folding inside the TRiC chaperonin.";
RL   Nat. Struct. Mol. Biol. 29:420-429(2022).
RN   [32] {ECO:0007744|PDB:7WZ3, ECO:0007744|PDB:7X0A, ECO:0007744|PDB:7X0S, ECO:0007744|PDB:7X0V, ECO:0007744|PDB:7X3J, ECO:0007744|PDB:7X3U, ECO:0007744|PDB:7X6Q, ECO:0007744|PDB:7X7Y}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.10 ANGSTROMS) IN COMPLEX WITH TUBULIN,
RP   FUNCTION, SUBUNIT, ATP; ADP AND MG(2+) BINDING SITES, AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=37193829; DOI=10.1038/s42003-023-04915-x;
RA   Liu C., Jin M., Wang S., Han W., Zhao Q., Wang Y., Xu C., Diao L., Yin Y.,
RA   Peng C., Peng C., Bao L., Wang Y., Cong Y.;
RT   "Pathway and mechanism of tubulin folding mediated by TRiC/CCT along its
RT   ATPase cycle revealed using cryo-EM.";
RL   Commun. Biol. 6:531-531(2023).
RN   [33]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-7.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [34]
RP   VARIANTS IDDPMGS LEU-38; 92-SER--ASP-556 DEL; ARG-159 AND 262-GLN--ASP-556
RP   DEL, CHARACTERIZATION OF VARIANTS IDDPMGS 92-SER--ASP-556 DEL; ARG-159 AND
RP   262-GLN--ASP-556 DEL, AND INVOLVEMENT IN IDDPMGS.
RX   PubMed=39480921; DOI=10.1126/science.adp8721;
RA   Kraft F., Rodriguez-Aliaga P., Yuan W., Franken L., Zajt K., Hasan D.,
RA   Lee T.T., Flex E., Hentschel A., Innes A.M., Zheng B., Julia Suh D.S.,
RA   Knopp C., Lausberg E., Krause J., Zhang X., Trapane P., Carroll R.,
RA   McClatchey M., Fry A.E., Wang L., Giesselmann S., Hoang H., Baldridge D.,
RA   Silverman G.A., Radio F.C., Bertini E., Ciolfi A., Blood K.A.,
RA   de Sainte Agathe J.M., Charles P., Bergant G., Cuturilo G., Peterlin B.,
RA   Diderich K., Streff H., Robak L., Oegema R., van Binsbergen E.,
RA   Herriges J., Saunders C.J., Maier A., Wolking S., Weber Y., Lochmueller H.,
RA   Meyer S., Aleman A., Polavarapu K., Nicolas G., Goldenberg A., Guyant L.,
RA   Pope K., Hehmeyer K.N., Monaghan K.G., Quade A., Smol T., Caumes R.,
RA   Duerinckx S., Depondt C., Van Paesschen W., Rieubland C., Poloni C.,
RA   Guipponi M., Arcioni S., Meuwissen M., Jansen A.C., Rosenblum J.,
RA   Haack T.B., Bertrand M., Gerstner L., Magg J., Riess O., Schulz J.B.,
RA   Wagner N., Wiesmann M., Weis J., Eggermann T., Begemann M., Roos A.,
RA   Haeusler M., Schedl T., Tartaglia M., Bremer J., Pak S.C., Frydman J.,
RA   Elbracht M., Kurth I.;
RT   "Brain malformations and seizures by impaired chaperonin function of
RT   TRiC.";
RL   Science 386:516-525(2024).
CC   -!- FUNCTION: Component of the chaperonin-containing T-complex (TRiC), a
CC       molecular chaperone complex that assists the folding of actin, tubulin
CC       and other proteins upon ATP hydrolysis (PubMed:25467444,
CC       PubMed:36493755, PubMed:35449234, PubMed:37193829). The TRiC complex
CC       mediates the folding of WRAP53/TCAB1, thereby regulating telomere
CC       maintenance (PubMed:25467444). As part of the TRiC complex may play a
CC       role in the assembly of BBSome, a complex involved in ciliogenesis
CC       regulating transports vesicles to the cilia (PubMed:20080638).
CC       {ECO:0000269|PubMed:20080638, ECO:0000269|PubMed:25467444,
CC       ECO:0000269|PubMed:35449234, ECO:0000269|PubMed:36493755,
CC       ECO:0000269|PubMed:37193829}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000305|PubMed:35449234, ECO:0000305|PubMed:36493755,
CC         ECO:0000305|PubMed:37193829};
CC   -!- SUBUNIT: Component of the chaperonin-containing T-complex (TRiC), a
CC       hexadecamer composed of two identical back-to-back stacked rings
CC       enclosing a protein folding chamber (PubMed:1630492, PubMed:20080638,
CC       PubMed:25467444, PubMed:36493755, PubMed:35449234, PubMed:37193829).
CC       Each ring is made up of eight different subunits: TCP1/CCT1, CCT2,
CC       CCT3, CCT4, CCT5, CCT6A/CCT6, CCT7, CCT8 (PubMed:36493755,
CC       PubMed:35449234, PubMed:37193829). Interacts with PACRG
CC       (PubMed:14532270). Interacts with GBA1 (PubMed:21098288). Interacts
CC       with DLEC1 (PubMed:33144677). {ECO:0000269|PubMed:14532270,
CC       ECO:0000269|PubMed:1630492, ECO:0000269|PubMed:20080638,
CC       ECO:0000269|PubMed:21098288, ECO:0000269|PubMed:25467444,
CC       ECO:0000269|PubMed:33144677, ECO:0000269|PubMed:35449234,
CC       ECO:0000269|PubMed:36493755, ECO:0000269|PubMed:37193829}.
CC   -!- INTERACTION:
CC       P17987; Q9Y2Y0: ARL2BP; NbExp=3; IntAct=EBI-356553, EBI-3449344;
CC       P17987; Q9ULD4-2: BRPF3; NbExp=3; IntAct=EBI-356553, EBI-23662416;
CC       P17987; O43439: CBFA2T2; NbExp=3; IntAct=EBI-356553, EBI-748628;
CC       P17987; P78371: CCT2; NbExp=8; IntAct=EBI-356553, EBI-357407;
CC       P17987; P50991: CCT4; NbExp=3; IntAct=EBI-356553, EBI-356876;
CC       P17987; P50990: CCT8; NbExp=3; IntAct=EBI-356553, EBI-356507;
CC       P17987; P04062: GBA1; NbExp=2; IntAct=EBI-356553, EBI-1564609;
CC       P17987; P83110: HTRA3; NbExp=5; IntAct=EBI-356553, EBI-2867394;
CC       P17987; P83110-1: HTRA3; NbExp=6; IntAct=EBI-356553, EBI-25469082;
CC       P17987; P83110-2: HTRA3; NbExp=7; IntAct=EBI-356553, EBI-22017714;
CC       P17987; P83105: HTRA4; NbExp=7; IntAct=EBI-356553, EBI-21776319;
CC       P17987; P42858: HTT; NbExp=3; IntAct=EBI-356553, EBI-466029;
CC       P17987; Q99759: MAP3K3; NbExp=2; IntAct=EBI-356553, EBI-307281;
CC       P17987; P78380: OLR1; NbExp=5; IntAct=EBI-356553, EBI-7151999;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:1630492}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:14654843, ECO:0000269|PubMed:20080638}.
CC   -!- DISEASE: Intellectual developmental disorder with polymicrogyria and
CC       seizures (IDDPMGS) [MIM:621021]: An autosomal dominant neurologic
CC       disorder characterized by a broad phenotypic spectrum. Main clinical
CC       features are developmental delay of varying severity, intellectual
CC       disability, seizures, and polymicrogyria. Additional variable features
CC       are non-specific pyramidal or cerebellar signs, and visual impairment.
CC       {ECO:0000269|PubMed:39480921}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the TCP-1 chaperonin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X52882; CAA37064.1; -; mRNA.
DR   EMBL; BT006969; AAP35615.1; -; mRNA.
DR   EMBL; AL135914; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW47616.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW47618.1; -; Genomic_DNA.
DR   EMBL; BC000665; AAH00665.1; -; mRNA.
DR   EMBL; M26885; AAA61059.1; -; Genomic_DNA.
DR   EMBL; M27272; AAA61060.1; -; Genomic_DNA.
DR   EMBL; M26889; AAA61060.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS5269.1; -.
DR   PIR; S10486; S10486.
DR   RefSeq; NP_110379.2; NM_030752.3.
DR   PDB; 6NR8; EM; 7.80 A; A/I=1-534.
DR   PDB; 6NR9; EM; 8.50 A; A/I=1-534.
DR   PDB; 6NRA; EM; 7.70 A; A/I=1-534.
DR   PDB; 6NRB; EM; 8.70 A; A/I=1-534.
DR   PDB; 6NRC; EM; 8.30 A; A/I=1-534.
DR   PDB; 6NRD; EM; 8.20 A; A/I=1-534.
DR   PDB; 6QB8; EM; 3.97 A; A/a=1-556.
DR   PDB; 7LUM; EM; 4.50 A; G/O=1-556.
DR   PDB; 7LUP; EM; 6.20 A; G/O=1-556.
DR   PDB; 7NVL; EM; 2.50 A; A/a=1-556.
DR   PDB; 7NVM; EM; 3.10 A; A/a=1-556.
DR   PDB; 7NVN; EM; 3.00 A; A/a=1-556.
DR   PDB; 7NVO; EM; 3.50 A; A/a=1-556.
DR   PDB; 7TRG; EM; 3.00 A; G=1-556.
DR   PDB; 7TTN; EM; 3.30 A; G=1-556.
DR   PDB; 7TTT; EM; 2.90 A; G=1-556.
DR   PDB; 7TUB; EM; 3.60 A; G=1-556.
DR   PDB; 7WU7; EM; 3.85 A; A/I=1-556.
DR   PDB; 7WZ3; EM; 4.10 A; A/a=1-556.
DR   PDB; 7X0A; EM; 3.10 A; A/a=1-556.
DR   PDB; 7X0S; EM; 3.10 A; A/a=1-556.
DR   PDB; 7X0V; EM; 3.20 A; A/a=1-556.
DR   PDB; 7X3J; EM; 4.20 A; A/a=1-556.
DR   PDB; 7X3U; EM; 3.30 A; A/a=1-556.
DR   PDB; 7X6Q; EM; 4.50 A; A/a=1-556.
DR   PDB; 7X7Y; EM; 3.80 A; A/a=1-556.
DR   PDB; 8HKI; EM; 3.10 A; A/a=1-556.
DR   PDB; 8I1U; EM; 3.24 A; A/I=1-556.
DR   PDB; 8I9U; EM; 3.10 A; A/I=1-556.
DR   PDB; 8IB8; EM; 4.42 A; A/I=1-556.
DR   PDB; 8SFE; EM; 3.36 A; A/a=2-537.
DR   PDB; 8SFF; EM; 3.20 A; A/a=2-537.
DR   PDB; 8SG8; EM; 3.00 A; A/a=2-537.
DR   PDB; 8SG9; EM; 2.90 A; A/a=2-537.
DR   PDB; 8SGC; EM; 2.90 A; A/a=2-537.
DR   PDB; 8SGL; EM; 2.90 A; A/a=2-537.
DR   PDB; 8SGQ; EM; 3.70 A; A/a=2-537.
DR   PDB; 8SH9; EM; 2.70 A; A/a=2-537.
DR   PDB; 8SHA; EM; 3.00 A; A/a=2-537.
DR   PDB; 8SHD; EM; 2.90 A; A/a=2-537.
DR   PDB; 8SHE; EM; 2.80 A; A/a=2-537.
DR   PDB; 8SHF; EM; 3.00 A; A/a=2-537.
DR   PDB; 8SHG; EM; 2.80 A; A/a=2-537.
DR   PDB; 8SHL; EM; 3.00 A; A/a=2-537.
DR   PDB; 8SHN; EM; 2.80 A; A/a=2-537.
DR   PDB; 8SHO; EM; 3.00 A; A/a=2-537.
DR   PDB; 8SHP; EM; 3.00 A; A/a=2-537.
DR   PDB; 8SHQ; EM; 2.90 A; A/a=2-537.
DR   PDB; 8SHT; EM; 3.00 A; A/a=2-537.
DR   PDBsum; 6NR8; -.
DR   PDBsum; 6NR9; -.
DR   PDBsum; 6NRA; -.
DR   PDBsum; 6NRB; -.
DR   PDBsum; 6NRC; -.
DR   PDBsum; 6NRD; -.
DR   PDBsum; 6QB8; -.
DR   PDBsum; 7LUM; -.
DR   PDBsum; 7LUP; -.
DR   PDBsum; 7NVL; -.
DR   PDBsum; 7NVM; -.
DR   PDBsum; 7NVN; -.
DR   PDBsum; 7NVO; -.
DR   PDBsum; 7TRG; -.
DR   PDBsum; 7TTN; -.
DR   PDBsum; 7TTT; -.
DR   PDBsum; 7TUB; -.
DR   PDBsum; 7WU7; -.
DR   PDBsum; 7WZ3; -.
DR   PDBsum; 7X0A; -.
DR   PDBsum; 7X0S; -.
DR   PDBsum; 7X0V; -.
DR   PDBsum; 7X3J; -.
DR   PDBsum; 7X3U; -.
DR   PDBsum; 7X6Q; -.
DR   PDBsum; 7X7Y; -.
DR   PDBsum; 8HKI; -.
DR   PDBsum; 8I1U; -.
DR   PDBsum; 8I9U; -.
DR   PDBsum; 8IB8; -.
DR   PDBsum; 8SFE; -.
DR   PDBsum; 8SFF; -.
DR   PDBsum; 8SG8; -.
DR   PDBsum; 8SG9; -.
DR   PDBsum; 8SGC; -.
DR   PDBsum; 8SGL; -.
DR   PDBsum; 8SGQ; -.
DR   PDBsum; 8SH9; -.
DR   PDBsum; 8SHA; -.
DR   PDBsum; 8SHD; -.
DR   PDBsum; 8SHE; -.
DR   PDBsum; 8SHF; -.
DR   PDBsum; 8SHG; -.
DR   PDBsum; 8SHL; -.
DR   PDBsum; 8SHN; -.
DR   PDBsum; 8SHO; -.
DR   PDBsum; 8SHP; -.
DR   PDBsum; 8SHQ; -.
DR   PDBsum; 8SHT; -.
DR   AlphaFoldDB; P17987; -.
DR   EMDB; EMD-0490; -.
DR   EMDB; EMD-0491; -.
DR   EMDB; EMD-0492; -.
DR   EMDB; EMD-0493; -.
DR   EMDB; EMD-0494; -.
DR   EMDB; EMD-0495; -.
DR   EMDB; EMD-12605; -.
DR   EMDB; EMD-12606; -.
DR   EMDB; EMD-12607; -.
DR   EMDB; EMD-12608; -.
DR   EMDB; EMD-13754; -.
DR   EMDB; EMD-23522; -.
DR   EMDB; EMD-23526; -.
DR   EMDB; EMD-26089; -.
DR   EMDB; EMD-26120; -.
DR   EMDB; EMD-26123; -.
DR   EMDB; EMD-26131; -.
DR   EMDB; EMD-32823; -.
DR   EMDB; EMD-32903; -.
DR   EMDB; EMD-32922; -.
DR   EMDB; EMD-32923; -.
DR   EMDB; EMD-32926; -.
DR   EMDB; EMD-32989; -.
DR   EMDB; EMD-32993; -.
DR   EMDB; EMD-33025; -.
DR   EMDB; EMD-33053; -.
DR   EMDB; EMD-34852; -.
DR   EMDB; EMD-35122; -.
DR   EMDB; EMD-35284; -.
DR   EMDB; EMD-35335; -.
DR   EMDB; EMD-40439; -.
DR   EMDB; EMD-40440; -.
DR   EMDB; EMD-40452; -.
DR   EMDB; EMD-40453; -.
DR   EMDB; EMD-40454; -.
DR   EMDB; EMD-40461; -.
DR   EMDB; EMD-40464; -.
DR   EMDB; EMD-40481; -.
DR   EMDB; EMD-40482; -.
DR   EMDB; EMD-40484; -.
DR   EMDB; EMD-40485; -.
DR   EMDB; EMD-40486; -.
DR   EMDB; EMD-40487; -.
DR   EMDB; EMD-40488; -.
DR   EMDB; EMD-40489; -.
DR   EMDB; EMD-40490; -.
DR   EMDB; EMD-40491; -.
DR   EMDB; EMD-40492; -.
DR   EMDB; EMD-40494; -.
DR   EMDB; EMD-4489; -.
DR   SMR; P17987; -.
DR   BioGRID; 112810; 639.
DR   ComplexPortal; CPX-6030; Chaperonin-containing T-complex.
DR   CORUM; P17987; -.
DR   DIP; DIP-33676N; -.
DR   FunCoup; P17987; 3731.
DR   IntAct; P17987; 341.
DR   MINT; P17987; -.
DR   STRING; 9606.ENSP00000317334; -.
DR   GlyGen; P17987; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P17987; -.
DR   MetOSite; P17987; -.
DR   PhosphoSitePlus; P17987; -.
DR   SwissPalm; P17987; -.
DR   BioMuta; TCP1; -.
DR   DMDM; 135538; -.
DR   OGP; P17987; -.
DR   REPRODUCTION-2DPAGE; IPI00290566; -.
DR   REPRODUCTION-2DPAGE; P17987; -.
DR   jPOST; P17987; -.
DR   MassIVE; P17987; -.
DR   PaxDb; 9606-ENSP00000317334; -.
DR   PeptideAtlas; P17987; -.
DR   PRIDE; P17987; -.
DR   ProteomicsDB; 53538; -.
DR   Pumba; P17987; -.
DR   Antibodypedia; 20023; 672 antibodies from 39 providers.
DR   DNASU; 6950; -.
DR   Ensembl; ENST00000321394.12; ENSP00000317334.7; ENSG00000120438.13.
DR   GeneID; 6950; -.
DR   KEGG; hsa:6950; -.
DR   MANE-Select; ENST00000321394.12; ENSP00000317334.7; NM_030752.3; NP_110379.2.
DR   UCSC; uc003qsr.4; human.
DR   AGR; HGNC:11655; -.
DR   ClinPGx; PA36406; -.
DR   CTD; 6950; -.
DR   DisGeNET; 6950; -.
DR   GeneCards; TCP1; -.
DR   HGNC; HGNC:11655; TCP1.
DR   HPA; ENSG00000120438; Low tissue specificity.
DR   MalaCards; TCP1; -.
DR   MIM; 186980; gene.
DR   MIM; 621021; phenotype.
DR   OpenTargets; ENSG00000120438; -.
DR   VEuPathDB; HostDB:ENSG00000120438; -.
DR   eggNOG; KOG0360; Eukaryota.
DR   GeneTree; ENSGT00550000074878; -.
DR   InParanoid; P17987; -.
DR   OMA; RGPNDYQ; -.
DR   OrthoDB; 496at2759; -.
DR   PAN-GO; P17987; 3 GO annotations based on evolutionary models.
DR   PhylomeDB; P17987; -.
DR   BRENDA; 3.6.4.B10; 2681.
DR   PathwayCommons; P17987; -.
DR   Reactome; R-HSA-389957; Prefoldin mediated transfer of substrate to CCT/TriC.
DR   Reactome; R-HSA-389960; Formation of tubulin folding intermediates by CCT/TriC.
DR   Reactome; R-HSA-390450; Folding of actin by CCT/TriC.
DR   Reactome; R-HSA-390471; Association of TriC/CCT with target proteins during biosynthesis.
DR   Reactome; R-HSA-5620922; BBSome-mediated cargo-targeting to cilium.
DR   Reactome; R-HSA-6814122; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding.
DR   Reactome; R-HSA-8950505; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation.
DR   SignaLink; P17987; -.
DR   SIGNOR; P17987; -.
DR   Agora; ENSG00000120438; -.
DR   BioGRID-ORCS; 6950; 820 hits in 1161 CRISPR screens.
DR   CD-CODE; 8C2F96ED; Centrosome.
DR   CD-CODE; DEE660B4; Stress granule.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; TCP1; human.
DR   GeneWiki; T-complex_1; -.
DR   GenomeRNAi; 6950; -.
DR   Pharos; P17987; Tbio.
DR   PRO; PR:P17987; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P17987; protein.
DR   Bgee; ENSG00000120438; Expressed in primordial germ cell in gonad and 200 other cell types or tissues.
DR   ExpressionAtlas; P17987; baseline and differential.
DR   GO; GO:0001669; C:acrosomal vesicle; IEA:Ensembl.
DR   GO; GO:0044297; C:cell body; IEA:Ensembl.
DR   GO; GO:0005813; C:centrosome; IDA:MGI.
DR   GO; GO:0005832; C:chaperonin-containing T-complex; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0000792; C:heterochromatin; IEA:Ensembl.
DR   GO; GO:0005874; C:microtubule; IDA:UniProtKB.
DR   GO; GO:0000242; C:pericentriolar material; IEA:Ensembl.
DR   GO; GO:0002199; C:zona pellucida receptor complex; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0140662; F:ATP-dependent protein folding chaperone; IEA:InterPro.
DR   GO; GO:0044183; F:protein folding chaperone; IDA:BHF-UCL.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0051082; F:unfolded protein binding; IBA:GO_Central.
DR   GO; GO:0007339; P:binding of sperm to zona pellucida; IEA:Ensembl.
DR   GO; GO:1904851; P:positive regulation of establishment of protein localization to telomere; IMP:BHF-UCL.
DR   GO; GO:1904871; P:positive regulation of protein localization to Cajal body; HMP:BHF-UCL.
DR   GO; GO:1904874; P:positive regulation of telomerase RNA localization to Cajal body; IMP:BHF-UCL.
DR   GO; GO:0032212; P:positive regulation of telomere maintenance via telomerase; IMP:BHF-UCL.
DR   GO; GO:0006457; P:protein folding; IDA:FlyBase.
DR   GO; GO:0050821; P:protein stabilization; IMP:BHF-UCL.
DR   GO; GO:0090666; P:scaRNA localization to Cajal body; IMP:BHF-UCL.
DR   GO; GO:0007021; P:tubulin complex assembly; NAS:UniProtKB.
DR   CDD; cd03335; TCP1_alpha; 1.
DR   FunFam; 3.50.7.10:FF:000009; T-complex protein 1 subunit alpha; 1.
DR   FunFam; 3.30.260.10:FF:000022; T-complex protein 1 subunit eta; 1.
DR   FunFam; 1.10.560.10:FF:000070; Uncharacterized protein; 1.
DR   FunFam; 3.30.260.10:FF:000040; Uncharacterized protein; 1.
DR   Gene3D; 3.50.7.10; GroEL; 1.
DR   Gene3D; 1.10.560.10; GroEL-like equatorial domain; 1.
DR   Gene3D; 3.30.260.10; TCP-1-like chaperonin intermediate domain; 1.
DR   InterPro; IPR012715; Chap_CCT_alpha.
DR   InterPro; IPR017998; Chaperone_TCP-1.
DR   InterPro; IPR002194; Chaperonin_TCP-1_CS.
DR   InterPro; IPR002423; Cpn60/GroEL/TCP-1.
DR   InterPro; IPR027409; GroEL-like_apical_dom_sf.
DR   InterPro; IPR027413; GROEL-like_equatorial_sf.
DR   InterPro; IPR027410; TCP-1-like_intermed_sf.
DR   InterPro; IPR053374; TCP-1_chaperonin.
DR   InterPro; IPR054827; thermosome_alpha.
DR   NCBIfam; TIGR02340; chap_CCT_alpha; 1.
DR   NCBIfam; NF041082; thermosome_alpha; 1.
DR   NCBIfam; NF041083; thermosome_beta; 1.
DR   PANTHER; PTHR11353; CHAPERONIN; 1.
DR   Pfam; PF00118; Cpn60_TCP1; 1.
DR   PRINTS; PR00304; TCOMPLEXTCP1.
DR   SUPFAM; SSF52029; GroEL apical domain-like; 1.
DR   SUPFAM; SSF48592; GroEL equatorial domain-like; 1.
DR   SUPFAM; SSF54849; GroEL-intermediate domain like; 1.
DR   PROSITE; PS00750; TCP1_1; 1.
DR   PROSITE; PS00751; TCP1_2; 1.
DR   PROSITE; PS00995; TCP1_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Chaperone; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Disease variant; Epilepsy; Hydrolase;
KW   Intellectual disability; Nucleotide-binding; Phosphoprotein;
KW   Proteomics identification; Reference proteome.
FT   CHAIN           1..556
FT                   /note="T-complex protein 1 subunit alpha"
FT                   /id="PRO_0000128302"
FT   BINDING         37
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:36493755, ECO:0007744|PDB:7NVL,
FT                   ECO:0007744|PDB:7NVM, ECO:0007744|PDB:7NVN,
FT                   ECO:0007744|PDB:7TTN, ECO:0007744|PDB:7TUB"
FT   BINDING         37
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7X3J"
FT   BINDING         88
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:36493755, ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7NVL, ECO:0007744|PDB:7NVM,
FT                   ECO:0007744|PDB:7NVN, ECO:0007744|PDB:7NVO,
FT                   ECO:0007744|PDB:7TRG, ECO:0007744|PDB:7TTN,
FT                   ECO:0007744|PDB:7TTT, ECO:0007744|PDB:7TUB,
FT                   ECO:0007744|PDB:7X0S, ECO:0007744|PDB:7X0V"
FT   BINDING         89
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:37193829, ECO:0007744|PDB:7NVL,
FT                   ECO:0007744|PDB:7NVM, ECO:0007744|PDB:7NVN,
FT                   ECO:0007744|PDB:7NVO, ECO:0007744|PDB:7X0S,
FT                   ECO:0007744|PDB:7X0V"
FT   BINDING         89
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7X3J"
FT   BINDING         90
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7X0S, ECO:0007744|PDB:7X0V"
FT   BINDING         90
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7X3J"
FT   BINDING         91
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:36493755, ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7NVL, ECO:0007744|PDB:7NVM,
FT                   ECO:0007744|PDB:7NVN, ECO:0007744|PDB:7TUB,
FT                   ECO:0007744|PDB:7X0S, ECO:0007744|PDB:7X0V,
FT                   ECO:0007744|PDB:7X3U"
FT   BINDING         91
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7X3J"
FT   BINDING         92
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:36493755, ECO:0007744|PDB:7NVL,
FT                   ECO:0007744|PDB:7NVM, ECO:0007744|PDB:7NVN,
FT                   ECO:0007744|PDB:7TTT, ECO:0007744|PDB:7TUB"
FT   BINDING         158
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:36493755, ECO:0007744|PDB:7NVL,
FT                   ECO:0007744|PDB:7NVM, ECO:0007744|PDB:7NVN,
FT                   ECO:0007744|PDB:7TRG, ECO:0007744|PDB:7TTN,
FT                   ECO:0007744|PDB:7TUB"
FT   BINDING         159
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0007744|PDB:7NVL"
FT   BINDING         412
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:36493755, ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7NVL, ECO:0007744|PDB:7NVN,
FT                   ECO:0007744|PDB:7NVO, ECO:0007744|PDB:7TRG,
FT                   ECO:0007744|PDB:7TTN, ECO:0007744|PDB:7TTT,
FT                   ECO:0007744|PDB:7TUB, ECO:0007744|PDB:7X0S,
FT                   ECO:0007744|PDB:7X0V"
FT   BINDING         505
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:36493755, ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7NVL, ECO:0007744|PDB:7NVO,
FT                   ECO:0007744|PDB:7TRG, ECO:0007744|PDB:7X0S,
FT                   ECO:0007744|PDB:7X0V"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000269|PubMed:12665801,
FT                   ECO:0007744|PubMed:19413330, ECO:0007744|PubMed:22223895,
FT                   ECO:0007744|PubMed:22814378"
FT   MOD_RES         6
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         181
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         199
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         400
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         491
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         494
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P11983"
FT   MOD_RES         544
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         551
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   VARIANT         7
FT                   /note="V -> L (in a breast cancer sample; somatic mutation;
FT                   dbSNP:rs537218073)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036258"
FT   VARIANT         38
FT                   /note="P -> L (in IDDPMGS; uncertain significance)"
FT                   /evidence="ECO:0000269|PubMed:39480921"
FT                   /id="VAR_090325"
FT   VARIANT         92..556
FT                   /note="Missing (in IDDPMGS; likely pathogenic; the
FT                   orthologous yeast mutation induces yeast lethality
FT                   suggesting loss of function)"
FT                   /evidence="ECO:0000269|PubMed:39480921"
FT                   /id="VAR_090326"
FT   VARIANT         159
FT                   /note="K -> R (in IDDPMGS; uncertain significance; the
FT                   orthologous yeast mutation induces yeast lethality
FT                   suggesting loss of function)"
FT                   /evidence="ECO:0000269|PubMed:39480921"
FT                   /id="VAR_090327"
FT   VARIANT         262..556
FT                   /note="Missing (in IDDPMGS; likely pathogenic; the
FT                   orthologous yeast mutation induces yeast lethality
FT                   suggesting loss of function)"
FT                   /evidence="ECO:0000269|PubMed:39480921"
FT                   /id="VAR_090328"
FT   CONFLICT        480
FT                   /note="R -> S (in Ref. 8; AAA61060)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        537..540
FT                   /note="SKDD -> ILRI (in Ref. 1; CAA37064)"
FT                   /evidence="ECO:0000305"
FT   TURN            3..5
FT                   /evidence="ECO:0007829|PDB:8SHD"
FT   STRAND          8..13
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           15..32
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           33..35
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          37..39
FT                   /evidence="ECO:0007829|PDB:8I9U"
FT   STRAND          42..46
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          48..50
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          52..55
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           58..64
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           70..85
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          86..88
FT                   /evidence="ECO:0007829|PDB:7NVO"
FT   HELIX           90..109
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           114..135
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          137..139
FT                   /evidence="ECO:0007829|PDB:7X0A"
FT   HELIX           140..143
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           146..156
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           160..164
FT                   /evidence="ECO:0007829|PDB:7X0A"
FT   HELIX           165..178
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          181..183
FT                   /evidence="ECO:0007829|PDB:7X0S"
FT   HELIX           184..186
FT                   /evidence="ECO:0007829|PDB:8SH9"
FT   STRAND          187..189
FT                   /evidence="ECO:0007829|PDB:7X0S"
FT   STRAND          194..199
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           205..207
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          209..217
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          223..225
FT                   /evidence="ECO:0007829|PDB:8SGC"
FT   STRAND          227..239
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          247..249
FT                   /evidence="ECO:0007829|PDB:8I9U"
FT   STRAND          250..252
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          254..256
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           257..259
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           260..280
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          285..290
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           294..303
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          306..308
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           313..323
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          328..331
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          334..338
FT                   /evidence="ECO:0007829|PDB:7TTT"
FT   HELIX           342..344
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          346..356
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          359..370
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          373..377
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           382..404
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          407..410
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   TURN            411..413
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           414..426
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           427..429
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           433..445
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           447..456
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           460..476
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           478..485
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          486..489
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   TURN            490..493
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          494..497
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           498..501
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          504..506
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           507..525
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          527..533
FT                   /evidence="ECO:0007829|PDB:7NVL"
SQ   SEQUENCE   556 AA;  60344 MW;  486ECA836EA258A1 CRC64;
     MEGPLSVFGD RSTGETIRSQ NVMAAASIAN IVKSSLGPVG LDKMLVDDIG DVTITNDGAT
     ILKLLEVEHP AAKVLCELAD LQDKEVGDGT TSVVIIAAEL LKNADELVKQ KIHPTSVISG
     YRLACKEAVR YINENLIVNT DELGRDCLIN AAKTSMSSKI IGINGDFFAN MVVDAVLAIK
     YTDIRGQPRY PVNSVNILKA HGRSQMESML ISGYALNCVV GSQGMPKRIV NAKIACLDFS
     LQKTKMKLGV QVVITDPEKL DQIRQRESDI TKERIQKILA TGANVILTTG GIDDMCLKYF
     VEAGAMAVRR VLKRDLKRIA KASGATILST LANLEGEETF EAAMLGQAEE VVQERICDDE
     LILIKNTKAR TSASIILRGA NDFMCDEMER SLHDALCVVK RVLESKSVVP GGGAVEAALS
     IYLENYATSM GSREQLAIAE FARSLLVIPN TLAVNAAQDS TDLVAKLRAF HNEAQVNPER
     KNLKWIGLDL SNGKPRDNKQ AGVFEPTIVK VKSLKFATEA AITILRIDDL IKLHPESKDD
     KHGSYEDAVH SGALND
//
